
Collaboration - February 12, 2025
Philanthropic partnership launches new initiative to tackle AMR
The Gates Foundation, Novo Nordisk Foundation, and Wellcome have announced the launch of the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI), a USD 50 million investment that will focus on combatting antimicrobial resistance (AMR) caused by a specific range of bacteria that are among the leading contributors to AMR-associated deaths.

Collaboration - February 11, 2025
60+ European companies launch the ‘EU AI Champions Initiative’
All participants are determined to establish Europe as a global leader in Artificial Intelligence (AI), advancing AI development and application.

Acquisition - February 10, 2025
Bain Capital acquires Mitsubishi Tanabe Pharma Corporation
Bain Capital has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation in a carve-out transaction from Mitsubishi Chemical Group Corporation.

Global report - January 24, 2025
AstraZeneca plans USD 570 million investment in Canada
The investment in Canada will create more than 700 high-skilled jobs, across all areas of the business.

Global report - January 21, 2025
Trump announces US withdrawal from WHO
President Donald Trump announced on Monday January 20 that the United States will leave the World Health Organization (WHO).

Acquisition - January 15, 2025
GSK to acquire IDRx for up to USD 1.15 billion
IDRx is a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of GIST.